| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99505f5f312672820e9f78c254c00a4d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a07c7ab25ad12c550bea397de8fa8d94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21a4cbb9691214801bdf0bff98043296 |
| publicationDate |
2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011189238-A1 |
| titleOfInvention |
Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation |
| abstract |
The invention relates to a novel use of the soluble forms of HLA-G in the treatment or prophylaxis of abnormal B-cell proliferation, such as liquid cancers of the B type. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021005001-A1 |
| priorityDate |
2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |